AM
AnGes, Inc.
AMGXF · OTC
$0.36 +0.00% (+$0.00)
Market Cap ¥22.4B
P/E Ratio -
Div. Yield -
ROE 162.36%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 109.83x
P/S 23.25x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 53.40%
Rev. growth 135.41%
FCF growth N/A
Profitability
18 /100
Weak Net margin 401.99%
Op. margin 621.56%
FCF margin 0.00%
Quality
3 /100
Poor ROE 162.36%
ROA 106.71%
Asset turnover 0.27x
Debt
8 /100
High Current ratio 0.95x
Int. coverage -388.66x
Debt/Equity 3.52x
Stability
26 /100
Unstable Rev. volatility 145.32%
EPS volatility 171.29%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AMGXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ei Yamada
Employees
56
Headquarters
Ibaraki
Evenimente viitoare
06 NOV.
Earnings
Upcoming earnings report